Skip to content

Catastrophism in Chronic Inflammatory Rheumatism

Catastrophism in Chronic Inflammatory Rheumatism

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04174092
Acronym
CRIC
Enrollment
533
Registered
2019-11-22
Start date
2019-10-27
Completion date
2022-12-17
Last updated
2023-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Inflammatory Rheumatism

Keywords

Catastrophism

Brief summary

Catastrophic is defined as a negative cognitive and emotional response based on inadequate pain expression. It has three components: rumination, amplification and vulnerability. The assessment of catastrophism is carried out using a validated questionnaire called the Pain Catatrophizing Scale (PCS). Recent studies highlight the significant impact of catastrophism in neuromuscular and mechanical rheumatic diseases such as gonarthrosis gonalgia and low back pain. In these diseases, it has been shown that catastrophism has a negative impact both on the experience of pain and on the response to different types of treatments (medical and surgical). Several studies have implemented multidisciplinary management and in particular cognitive-behavioural therapy with an improvement in the pain experience in patients who are catastrophic. In chronic inflammatory rheumatic diseases such as rheumatoid arthritis, spondyloarthritis and psoriatic arthritis, the prevalence and impact of catastrophism is still poorly understood.

Interventions

OTHERcompleting self-questionnaires

completing self-questionnaires on quality of life, anxiety, insomnia, activity of rheumatic disease and catastrophism

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Major patients, hospital follow-up, with RA according to ACR 2010 criteria, or spondyloarthritis according to ASAS 2009 criteria or according to AMOR or psoriatic arthritis according to Caspar 2006 criteria. * Patient who has given free and informed consent. * Patient who has signed the consent form. * Patient affiliated or benefiting from a health insurance plan. * Adult patient (≥18 years old).

Exclusion criteria

* Patient under the protection of justice, under guardianship or curatorship. * Patient unable to express consent. * Patient for whom it is impossible to provide informed information. * Poor command and understanding of the French language making it impossible to complete self-questionnaires

Design outcomes

Primary

MeasureTime frameDescription
catastrophic assessmentDay 0Pain Catastrophism Scale (0= no catastrophism, 52 = maximum catastrophism)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026